-
1
-
-
1942456786
-
-
R. Wijtmans, M. K. S. Vink, H. E. Schoemaker, F. L. van Delft, R. H. Blaauw, F P. J. T. Rutjes, Synthesis 2004, 641-662.
-
(2004)
Synthesis
, pp. 641-662
-
-
Wijtmans, R.1
Vink, M.K.S.2
Schoemaker, H.E.3
van Delft, F.L.4
Blaauw, R.H.5
Rutjes, F.P.J.T.6
-
2
-
-
17544404431
-
-
a) E. H. F. Wong, M. S. Sonders, S. G. Amara, P. M. Tinholt, M. F. P. Piercey, W. P. Hoffmann, D. K. Hyslop, S. Franklin, R. D. Porsolt, A. Bonsignori, N. Carfagna, R. A. McArthur, Biol. Psychiatry 2000, 47, 818-829;
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 818-829
-
-
Wong, E.H.F.1
Sonders, M.S.2
Amara, S.G.3
Tinholt, P.M.4
Piercey, M.F.P.5
Hoffmann, W.P.6
Hyslop, D.K.7
Franklin, S.8
Porsolt, R.D.9
Bonsignori, A.10
Carfagna, N.11
McArthur, R.A.12
-
4
-
-
0032425787
-
-
2: a J. Ong, D. I. B. Kerr, H. Bittiger, P. C. Waldmeier, P. A. Baumann, N. G. Cooke, S. J. Mickel, W. Froestl, Eur. J. Pharmacol. 1998, 362, 27-34;
-
2: a) J. Ong, D. I. B. Kerr, H. Bittiger, P. C. Waldmeier, P. A. Baumann, N. G. Cooke, S. J. Mickel, W. Froestl, Eur. J. Pharmacol. 1998, 362, 27-34;
-
-
-
-
5
-
-
34250624134
-
-
3: b S. Kawashima, T. Matsuno, S. Yaguchi, H. Sasahara, T. Watanabe, T. PCT Int. Appl. WO 02088112, 2002;
-
3: b) S. Kawashima, T. Matsuno, S. Yaguchi, H. Sasahara, T. Watanabe, T. PCT Int. Appl. WO 02088112, 2002;
-
-
-
-
6
-
-
34250631417
-
-
4: c R. A. Ancliff, C. M. Cook, C. D. Eldred, P. M. Gore, L. A. Harrison, M. A. Hayes, S. T. Hodgson, D. B. Judd, S. E. Keeling, X. Q. Lewell, G. Mills, G. M. Robertson, S. Swanson, A. J. Walker, M. Wilkinson, PCT Int. Appl. WO 03082861, 2003;
-
4: c) R. A. Ancliff, C. M. Cook, C. D. Eldred, P. M. Gore, L. A. Harrison, M. A. Hayes, S. T. Hodgson, D. B. Judd, S. E. Keeling, X. Q. Lewell, G. Mills, G. M. Robertson, S. Swanson, A. J. Walker, M. Wilkinson, PCT Int. Appl. WO 03082861, 2003;
-
-
-
-
7
-
-
0026073882
-
-
5: d S. Kato, T. Morie, T. Kon, N. Yoshida, T. Karasawa, J. Matsumoto, J. Med. Chem. 1991, 34, 616-624.
-
5: d) S. Kato, T. Morie, T. Kon, N. Yoshida, T. Karasawa, J. Matsumoto, J. Med. Chem. 1991, 34, 616-624.
-
-
-
-
8
-
-
34250625754
-
-
For modifications of the 2-(hydroxymethyl) group in morpholines of type 6, see refs.[5a,5b,9,11a
-
[5a,5b,9,11a]
-
-
-
-
9
-
-
0141787020
-
-
For non-stereoselective syntheses of morpholines of type 6, see: a
-
For non-stereoselective syntheses of morpholines of type 6, see: a) J. A. H. Lainton, M. C. Allen, M. Burton, S. Cameron, T. R. G. Edwards, G. Harden, R. Hogg, W. Leung, S. Miller, J. J. Morrish, S. M. Rooke, B. Wendt, J. Comb. Chem. 2003, 5, 400-407;
-
(2003)
J. Comb. Chem
, vol.5
, pp. 400-407
-
-
Lainton, J.A.H.1
Allen, M.C.2
Burton, M.3
Cameron, S.4
Edwards, T.R.G.5
Harden, G.6
Hogg, R.7
Leung, W.8
Miller, S.9
Morrish, J.J.10
Rooke, S.M.11
Wendt, B.12
-
10
-
-
0028215792
-
-
b) T. Morie, S. Kato, H. Harada, N. Yoshida, J.-i. Matsumoto, Chem. Pharm. Bull. 1994, 42, 877-882;
-
(1994)
Chem. Pharm. Bull
, vol.42
, pp. 877-882
-
-
Morie, T.1
Kato, S.2
Harada, H.3
Yoshida, N.4
Matsumoto, J.-I.5
-
13
-
-
8444232793
-
-
For non-stereoselective syntheses of 2-substituted morpholines see: a
-
For non-stereoselective syntheses of 2-substituted morpholines see: a) V. Lupi, D. Albanese, D. Landini, D. Scaletti, M. Penso, Tetrahedron 2004, 60, 11709-11718;
-
(2004)
Tetrahedron
, vol.60
, pp. 11709-11718
-
-
Lupi, V.1
Albanese, D.2
Landini, D.3
Scaletti, D.4
Penso, M.5
-
14
-
-
0034635846
-
-
b) T. Takemoto, Y. Iio, T. Nishi, Tetrahedron Lett. 2000, 41, 1785-1788;
-
(2000)
Tetrahedron Lett
, vol.41
, pp. 1785-1788
-
-
Takemoto, T.1
Iio, Y.2
Nishi, T.3
-
15
-
-
0030576292
-
-
c) D. J. Blythin, S.-C. Kuo, H.-J. Shue, A. T. McPhail, R. W. Chapman, W. Kreutner, C. Rizzo, H. S. She, R. West, Bioorg. Med. Chem. Lett. 1996, 6, 1529-1534;
-
(1996)
Bioorg. Med. Chem. Lett
, vol.6
, pp. 1529-1534
-
-
Blythin, D.J.1
Kuo, S.-C.2
Shue, H.-J.3
McPhail, A.T.4
Chapman, R.W.5
Kreutner, W.6
Rizzo, C.7
She, H.S.8
West, R.9
-
16
-
-
1642460110
-
-
d) A. Dobrev, J. J. Perie, A. Lattes, Tetrahedron Lett. 1972, 13, 4013-4016.
-
(1972)
Tetrahedron Lett
, vol.13
, pp. 4013-4016
-
-
Dobrev, A.1
Perie, J.J.2
Lattes, A.3
-
18
-
-
34250681876
-
-
Ref.[5b
-
[5b]
-
-
-
-
19
-
-
1642486447
-
-
For a related procedure leading to 2-(siloxyalkyl)-substituted morpholines, see
-
b) For a related procedure leading to 2-(siloxyalkyl)-substituted morpholines, see: B. A. Lanman, A. G. Myers, Org. Lett. 2004, 6, 1045-1047.
-
(2004)
Org. Lett
, vol.6
, pp. 1045-1047
-
-
Lanman, B.A.1
Myers, A.G.2
-
20
-
-
15044347050
-
-
E. Brenner, R. M. Baldwin, G. Tamagnan, Org. Lett. 2005, 7, 937-939.
-
(2005)
Org. Lett
, vol.7
, pp. 937-939
-
-
Brenner, E.1
Baldwin, R.M.2
Tamagnan, G.3
-
21
-
-
0028791862
-
-
G. Sunn, P. S. Savle, R. D. Gandour, N. N. a' Bhaírd, R. R. Ramsay, F. R. Fronczek, J. Org. Chem. 1995, 60, 6688-6695.
-
(1995)
J. Org. Chem
, vol.60
, pp. 6688-6695
-
-
Sunn, G.1
Savle, P.S.2
Gandour, R.D.3
a' Bhaírd, N.N.4
Ramsay, R.R.5
Fronczek, F.R.6
-
22
-
-
20444362011
-
-
M. C. Wilkinson, Tetrahedron Lett. 2005, 46, 4773-4775 and references cited therein;
-
a) M. C. Wilkinson, Tetrahedron Lett. 2005, 46, 4773-4775 and references cited therein;
-
-
-
-
23
-
-
33751385275
-
-
b) Y. Uozumi, A. Tanahashi, T. Hayashi, J. Org. Chem. 1993, 58, 6826-6832.
-
(1993)
J. Org. Chem
, vol.58
, pp. 6826-6832
-
-
Uozumi, Y.1
Tanahashi, A.2
Hayashi, T.3
-
24
-
-
33751333267
-
-
For a review on the asymmetric ring opening of epoxides with carbon nucleophiles, see
-
For a review on the asymmetric ring opening of epoxides with carbon nucleophiles, see: M. Pineschi, Eur. J. Org. Chem. 2006, 4979-4988.
-
(2006)
Eur. J. Org. Chem
, pp. 4979-4988
-
-
Pineschi, M.1
-
25
-
-
34250665535
-
-
Eds, R. M. Coates, S. E. Denmark, Wiley, New York
-
J. E. Huber, in: Handbook of Reagents for Organic Synthesis: Reagents, Auxiliaries and Catalysts for C-C bonds (Eds.: R. M. Coates, S. E. Denmark), Wiley, New York, 1999, p. 350-352.
-
(1999)
Handbook of Reagents for Organic Synthesis: Reagents, Auxiliaries and Catalysts for C-C bonds
, pp. 350-352
-
-
Huber, J.E.1
-
26
-
-
0033025182
-
-
a) A. Dobrev, L. Nechev, C. Iwanow, M. Bon, J. Chem. Res. (S) 1999, 3, 188-189;
-
(1999)
J. Chem. Res. (S)
, vol.3
, pp. 188-189
-
-
Dobrev, A.1
Nechev, L.2
Iwanow, C.3
Bon, M.4
-
27
-
-
34250614782
-
-
J. Chem. Res. (M) 1999, 3, 1001-1047;
-
(1999)
, Issue.3
, pp. 1001-1047
-
-
Chem, J.1
Res, M.2
-
29
-
-
34250666737
-
-
ref.[5a
-
[5a]
-
-
-
-
30
-
-
33845185491
-
-
K. C. Nicolaou, C. V. C. Prasad, P. K. Somers, C.-K. Hwang, J. Am. Chem. Soc. 1989, 111, 5335-5340.
-
(1989)
J. Am. Chem. Soc
, vol.111
, pp. 5335-5340
-
-
Nicolaou, K.C.1
Prasad, C.V.C.2
Somers, P.K.3
Hwang, C.-K.4
-
32
-
-
34250668472
-
-
This was necessary in order to exclude the formation of oxazepanes 11 or epoxides 10 see Scheme 2 and Table 2, which possess identical masses and would provide similar 1H and 13C NMR spectra
-
13C NMR spectra.
-
-
-
-
33
-
-
0022356177
-
-
For the debenzylation of 6a, see: a T. Kojima, K. Niigata, T. Fujikura, S. Tachikawa, Y. Nozaki, S. Kagami, K. Takahashi, Chem. Pharm. Bull. 1985, 33, 3766-3774;
-
For the debenzylation of 6a, see: a) T. Kojima, K. Niigata, T. Fujikura, S. Tachikawa, Y. Nozaki, S. Kagami, K. Takahashi, Chem. Pharm. Bull. 1985, 33, 3766-3774;
-
-
-
-
34
-
-
0028064884
-
-
b) Y Jinbo, H. Kondo, M. Taguchi, Y. Inoue, F. Sakamoto, G. Tsukamoto, J. Med. Chem. 1994, 37, 2791-2796;
-
(1994)
J. Med. Chem
, vol.37
, pp. 2791-2796
-
-
Jinbo, Y.1
Kondo, H.2
Taguchi, M.3
Inoue, Y.4
Sakamoto, F.5
Tsukamoto, G.6
-
35
-
-
34250687181
-
-
ref.[14b
-
[14b]
-
-
-
-
36
-
-
34250685856
-
-
1H NMR spectra of the crude reaction mixtures. Nevertheless, the formation of small amounts of diastereomeric byproducts cannot be excluded.
-
1H NMR spectra of the crude reaction mixtures. Nevertheless, the formation of small amounts of diastereomeric byproducts cannot be excluded.
-
-
-
-
38
-
-
0033927019
-
-
a) F. Roussi, A. Chauveau, M. Bonin, L. Micouin, H.-P. Husson, Synthesis 2000, 1170-1179;
-
(2000)
Synthesis
, pp. 1170-1179
-
-
Roussi, F.1
Chauveau, A.2
Bonin, M.3
Micouin, L.4
Husson, H.-P.5
-
39
-
-
0034602380
-
-
b) S. R. Hitchcock, G. P. Nora, C. Hedberg, D. M. Casper, L. S. Buchanan, M. D. Squire, D. X. West, Tetrahedron 2000, 56, 8799-8807.
-
(2000)
Tetrahedron
, vol.56
, pp. 8799-8807
-
-
Hitchcock, S.R.1
Nora, G.P.2
Hedberg, C.3
Casper, D.M.4
Buchanan, L.S.5
Squire, M.D.6
West, D.X.7
-
41
-
-
4143066159
-
-
T. Itoh, K. Nagata, M. Miyazaki, H. Ishikawa, A. Kurihara, A. Ohsawa, Tetrahedron 2004, 60, 6649-6655.
-
(2004)
Tetrahedron
, vol.60
, pp. 6649-6655
-
-
Itoh, T.1
Nagata, K.2
Miyazaki, M.3
Ishikawa, H.4
Kurihara, A.5
Ohsawa, A.6
-
42
-
-
0036976021
-
-
T. Matsui, T. Kondo, Y. Nishita, S. Itadani, H. Tsuruta, S. Fujita, N. Omawari, M. Sakai, S. Nakazawa, A. Ogata, H. Mori, W. Kamoshima, K. Terai, H. Ohno, T. Obata, H. Nakai, M. Toda, Bioorg. Med. Chem. 2002, 10, 3787-3808.
-
(2002)
Bioorg. Med. Chem
, vol.10
, pp. 3787-3808
-
-
Matsui, T.1
Kondo, T.2
Nishita, Y.3
Itadani, S.4
Tsuruta, H.5
Fujita, S.6
Omawari, N.7
Sakai, M.8
Nakazawa, S.9
Ogata, A.10
Mori, H.11
Kamoshima, W.12
Terai, K.13
Ohno, H.14
Obata, T.15
Nakai, H.16
Toda, M.17
-
43
-
-
34250663158
-
-
[5d,14a,14b]
-
[5d,14a,14b]
-
-
-
|